4 completed, 1 terminated. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 4, Terminated 1 |
Follow Comirnaty: new trials by email Literature Review of Comirnaty trials Research Report on Comirnaty
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction Pfizer-BioNTech mRNA COVID-19 vaccine, Moderna mRNA COVID-19 vaccine - COVID-19, Corona Virus Infection | Phase 4 | Completed | University of Michigan | 137 | 2022-03-21 | 2026-03-27 |
| Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction Tozinameran - COVID-19, Vaccine Reaction | Phase 4 | Completed | Murdoch Childrens Research Institute | 51 | 2022-01-20 | 2023-02-09 |
| COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 Spikevax, Comirnaty, Spikevax bivalent Original/Omicron BA.1 - Cancer | Phase 4 | Terminated | Jules Bordet Institute | 152 | 2021-12-01 | 2024-01-17 |
| Randomized Trial of COVID-19 Booster Vaccinations (Cobovax Study) BNT162b2, CoronaVac - COVID-19 Vaccination | Phase 4 | Completed | The University of Hong Kong | 451 | 2021-11-18 | 2026-05-15 |
| Third Dose of mRNA Vaccination to Boost COVID-19 Immunity (mBoost Study) BNT162b2 - COVID 19 Vaccine | Phase 4 | Completed | The University of Hong Kong | 300 | 2021-10-18 | 2026-05-15 |
COVID-19 (3) · Coronavirus Infections (1) · Hypersensitivity (1) · Infections (1) · Neoplasms (1)
The University of Hong Kong (2) · Jules Bordet Institute (1) · Murdoch Childrens Research Institute (1) · University of Michigan (1)
Hong Kong (2) · Australia (1) · Belgium (1) · United States (1)
Benjamin J Cowling, PhD (2) · James Baker, MD (1) · Nigel Curtis (1)